Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
970.3 USD | +0.32% | -1.04% | +10.48% |
10:50am | Regeneron Pharmaceuticals, Sanofi Say Dupixent FDA Application Decision Delayed by 3 Months | MT |
07:50am | Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S. | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.48% | 105B | |
+8.92% | 114B | |
-2.85% | 21.73B | |
-6.45% | 23.83B | |
-10.65% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B | |
+83.87% | 9.19B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Transcript : Regeneron Pharmaceuticals, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2023, May-16-2023 09